142 related articles for article (PubMed ID: 8478229)
41. Neoadjuvant chemoradiation in pancreatic and duodenal carcinoma. A Phase II Study.
Yeung RS; Weese JL; Hoffman JP; Solin LJ; Paul AR; Engstrom PF; Litwin S; Kowalyshyn MJ; Eisenberg BL
Cancer; 1993 Oct; 72(7):2124-33. PubMed ID: 8374871
[TBL] [Abstract][Full Text] [Related]
42. Preoperative treatment of patients with locally advanced unresectable rectal adenocarcinoma utilizing continuous chronobiologically shaped 5-fluorouracil infusion and radiation therapy.
Marsh RD; Chu NM; Vauthey JN; Mendenhall WM; Lauwers GY; Bewsher C; Copeland EM
Cancer; 1996 Jul; 78(2):217-25. PubMed ID: 8673995
[TBL] [Abstract][Full Text] [Related]
43. Five fractions of preoperative radiotherapy for selected cases of rectal carcinoma: long-term tumor control and tolerance to treatment.
Myerson RJ; Genovesi D; Lockett MA; Birnbaum E; Fleshman J; Fry R; Kodner I; Menteer J; Picus J; Read T; Walz B
Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):537-43. PubMed ID: 10078634
[TBL] [Abstract][Full Text] [Related]
44. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?
Kuo LJ; Liu MC; Jian JJ; Horng CF; Cheng TI; Chen CM; Fang WT; Chung YL
Ann Surg Oncol; 2007 Oct; 14(10):2766-72. PubMed ID: 17551794
[TBL] [Abstract][Full Text] [Related]
45. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.
Bonnen M; Crane C; Vauthey JN; Skibber J; Delclos ME; Rodriguez-Bigas M; Hoff PM; Lin E; Eng C; Wong A; Janjan NA; Feig BW
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1098-105. PubMed ID: 15519780
[TBL] [Abstract][Full Text] [Related]
46. Preoperative radiochemotherapy and sphincter-saving resection for T3 carcinomas of the lower third of the rectum.
Rullier E; Goffre B; Bonnel C; Zerbib F; Caudry M; Saric J
Ann Surg; 2001 Nov; 234(5):633-40. PubMed ID: 11685026
[TBL] [Abstract][Full Text] [Related]
47. High dose rate intraoperative radiation therapy (HDR-IORT) as part of the management strategy for locally advanced primary and recurrent rectal cancer.
Harrison LB; Minsky BD; Enker WE; Mychalczak B; Guillem J; Paty PB; Anderson L; White C; Cohen AM
Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):325-30. PubMed ID: 9788411
[TBL] [Abstract][Full Text] [Related]
48. Locally advanced rectal carcinoma: pelvic control and morbidity following preoperative radiation therapy, resection, and intraoperative radiation therapy.
Kim HK; Jessup JM; Beard CJ; Bornstein B; Cady B; Stone MD; Bleday R; Bothe A; Steele G; Busse PM
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):777-83. PubMed ID: 9240646
[TBL] [Abstract][Full Text] [Related]
49. A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group Study.
Glynne-Jones R; Falk S; Maughan TS; Meadows HM; Sebag-Montefiore D
Br J Cancer; 2007 Feb; 96(4):551-8. PubMed ID: 17262086
[TBL] [Abstract][Full Text] [Related]
50. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.
Bosset JF; Calais G; Mineur L; Maingon P; Stojanovic-Rundic S; Bensadoun RJ; Bardet E; Beny A; Ollier JC; Bolla M; Marchal D; Van Laethem JL; Klein V; Giralt J; Clavère P; Glanzmann C; Cellier P; Collette L;
Lancet Oncol; 2014 Feb; 15(2):184-90. PubMed ID: 24440473
[TBL] [Abstract][Full Text] [Related]
51. Adjuvant radiation therapy for rectal carcinoma: predictors of outcome.
Myerson RJ; Michalski JM; King ML; Birnbaum E; Fleshman J; Fry R; Kodner I; Lacey D; Lockett MA
Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):41-50. PubMed ID: 7721638
[TBL] [Abstract][Full Text] [Related]
52. Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: a randomized trial.
Lorvidhaya V; Chitapanarux I; Sangruchi S; Lertsanguansinchai P; Kongthanarat Y; Tangkaratt S; Visetsiri E
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1226-32. PubMed ID: 12654431
[TBL] [Abstract][Full Text] [Related]
53. Preoperative "chemoradiation" for stages II and III rectal carcinoma.
Stryker SJ; Kiel KD; Rademaker A; Shaw JM; Ujiki GT; Poticha SM
Arch Surg; 1996 May; 131(5):514-8; discussion 518-9. PubMed ID: 8624198
[TBL] [Abstract][Full Text] [Related]
54. Neoadjuvant sandwich treatment with oxaliplatin and capecitabine administered prior to, concurrently with, and following radiation therapy in locally advanced rectal cancer: a prospective phase 2 trial.
Gao YH; Lin JZ; An X; Luo JL; Cai MY; Cai PQ; Kong LH; Liu GC; Tang JH; Chen G; Pan ZZ; Ding PR
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1153-60. PubMed ID: 25442042
[TBL] [Abstract][Full Text] [Related]
55. Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5-Year Clinical Outcomes ECOG-ACRIN Cancer Research Group E3204.
Landry JC; Feng Y; Prabhu RS; Cohen SJ; Staley CA; Whittington R; Sigurdson ER; Nimeiri H; Verma U; Benson AB
Oncologist; 2015 Jun; 20(6):615-6. PubMed ID: 25926352
[TBL] [Abstract][Full Text] [Related]
56. Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy.
Minsky BD; Cohen AM; Kemeny N; Enker WE; Kelsen DP; Reichman B; Saltz L; Sigurdson ER; Frankel J
J Clin Oncol; 1992 Jan; 10(1):79-84. PubMed ID: 1727928
[TBL] [Abstract][Full Text] [Related]
57. Prognostic significance of tumor fixation of rectal carcinoma. Implications for adjunctive radiation therapy.
Mohiuddin M; Regine WF; Marks G
Cancer; 1996 Aug; 78(4):717-22. PubMed ID: 8756362
[TBL] [Abstract][Full Text] [Related]
58. Long-term results of infusional 5-FU, mitomycin-C and radiation as primary management of esophageal carcinoma.
Coia LR; Engstrom PF; Paul AR; Stafford PM; Hanks GE
Int J Radiat Oncol Biol Phys; 1991 Jan; 20(1):29-36. PubMed ID: 1704362
[TBL] [Abstract][Full Text] [Related]
59. Long-term results of reirradiation for patients with recurrent rectal carcinoma.
Mohiuddin M; Marks G; Marks J
Cancer; 2002 Sep; 95(5):1144-50. PubMed ID: 12209702
[TBL] [Abstract][Full Text] [Related]
60. The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumor response, leading to increased sphincter preservation in locally advanced rectal cancer.
Crane CH; Skibber JM; Birnbaum EH; Feig BW; Singh AK; Delclos ME; Lin EH; Fleshman JW; Thames HD; Kodner IJ; Lockett MA; Picus J; Phan T; Chandra A; Janjan NA; Read TE; Myerson RJ
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):84-9. PubMed ID: 12909219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
